import MedicalConditionPage from "@/components/MedicalConditionPage";

export default function BrainTumor() {
  return (
    <MedicalConditionPage
      metaTitle="Brain Tumor Treatment in Germany | Specialist Neurosurgery"
      metaDescription="Structured access to neurosurgical and neuro-oncological expertise at German university hospitals for brain tumor diagnosis and treatment planning."
      canonicalPath="/brain-tumor-treatment-germany"
      headline="Brain Tumor Treatment in Germany"
      subtitle="Structured access to neurosurgical and neuro-oncological expertise at German university hospitals."
      introduction="Brain tumors represent one of the most complex categories of neurological disease, requiring a precise convergence of diagnostic imaging, molecular pathology, neurosurgery, radiation oncology, and systemic treatment. German university hospitals operate dedicated neuro-oncology units where these disciplines intersect within structured multidisciplinary tumor boards. Each case is reviewed collectively before any treatment decision is finalized, ensuring that the selected pathway reflects the full clinical picture rather than a single specialist perspective."
      aboutCondition="Brain tumors encompass a broad spectrum of intracranial neoplasms. They may be primary — arising directly from brain tissue, meninges, or cranial nerves — or secondary, representing metastases from cancers originating in the lung, breast, kidney, or other organ systems. Primary brain tumors are further classified by cell type and malignancy grade according to the World Health Organization (WHO) classification system, which ranges from Grade I (slow-growing, often benign) to Grade IV (rapidly progressive, such as glioblastoma multiforme). Molecular profiling, including IDH mutation status, MGMT promoter methylation, and 1p/19q codeletion analysis, has become integral to both prognosis and treatment selection in modern neuro-oncology."
      symptoms={[
        "Persistent or progressive headaches, often worse in the morning",
        "Unexplained nausea or vomiting not related to gastrointestinal illness",
        "New-onset seizures in an adult without prior epilepsy history",
        "Focal neurological deficits such as weakness, numbness, or speech difficulty",
        "Visual disturbances including double vision or peripheral field loss",
        "Cognitive changes, memory impairment, or personality alterations",
        "Balance difficulties or coordination problems",
        "Fatigue disproportionate to activity level"
      ]}
      causes="The precise etiology of most primary brain tumors remains incompletely understood. Established risk factors include prior cranial radiation therapy, certain hereditary syndromes such as neurofibromatosis type 1 and 2, Li-Fraumeni syndrome, and von Hippel-Lindau disease. Immunosuppression, whether from disease or medication, increases the risk of primary central nervous system lymphoma. Secondary brain tumors arise from systemic malignancies that have metastasized to the brain via hematogenous spread. Lung carcinoma, breast carcinoma, renal cell carcinoma, melanoma, and colorectal cancer account for the majority of brain metastases encountered in clinical practice."
      diagnosticProcess="Diagnostic evaluation at German university hospitals begins with high-resolution MRI of the brain with and without gadolinium contrast, typically supplemented by advanced sequences including diffusion-weighted imaging, perfusion MRI, and MR spectroscopy to characterize tumor biology non-invasively. Where indicated, CT imaging provides complementary information regarding calcification and bony involvement. Positron emission tomography (PET) using amino acid tracers such as FET or MET offers additional metabolic characterization. Tissue diagnosis through stereotactic biopsy or surgical resection enables histopathological grading and molecular profiling according to current WHO CNS tumor classification standards. Cerebrospinal fluid analysis may be performed where leptomeningeal involvement is suspected."
      treatmentOptions="Treatment planning at German neuro-oncology centers is individualized and multidisciplinary. Surgical resection aims to achieve maximal safe tumor removal while preserving neurological function, guided by intraoperative MRI, neuronavigation, awake craniotomy with cortical mapping, and fluorescence-guided surgery using 5-ALA. Radiation therapy is delivered using modern linear accelerators capable of stereotactic radiosurgery (Gamma Knife, CyberKnife) or fractionated stereotactic radiotherapy for larger lesions. Systemic treatment with temozolomide chemotherapy, bevacizumab, or tumor treating fields (TTFields) may be integrated depending on tumor histology and molecular markers. Participation in clinical trials investigating novel immunotherapeutic and targeted agents is available at major German cancer centers."
      treatmentList={[
        "Maximal safe surgical resection with intraoperative MRI and neuronavigation",
        "Awake craniotomy with cortical and subcortical mapping for eloquent area tumors",
        "Stereotactic radiosurgery (SRS) for small or surgically inaccessible lesions",
        "Fractionated stereotactic radiotherapy (FSRT) for larger or recurrent tumors",
        "Temozolomide-based chemotherapy per STUPP protocol for glioblastoma",
        "Tumor treating fields (TTFields) as adjunct to standard glioblastoma therapy",
        "Targeted therapy and immunotherapy within clinical trial frameworks",
        "Whole brain radiotherapy (WBRT) for multiple brain metastases"
      ]}
      whyGermany="Germany's university medical centers maintain dedicated neuro-oncology programs that combine surgical expertise, advanced radiation technology, and molecular oncology within a single institutional framework. Intraoperative MRI suites, which allow real-time imaging during surgery to assess resection extent, are available at major German neurosurgical centers. The German Society for Neuro-Oncology (DGNC/NOA) coordinates national treatment guidelines and clinical trial networks, ensuring that patients treated in Germany benefit from evidence-based protocols aligned with international standards. Multidisciplinary tumor boards convene regularly to review complex cases, and the integration of neuropathology, neuroradiology, and molecular diagnostics within the same institution reduces delays between diagnosis and treatment initiation."
      specialistEvaluation="A specialist evaluation begins with a structured review of all available imaging studies, pathology reports, and prior treatment records. German neuro-oncologists assess whether the current diagnosis is complete, whether additional molecular diagnostics are indicated, and whether the proposed or prior treatment plan aligns with current evidence-based guidelines. For patients who have already undergone surgery or radiotherapy elsewhere, the evaluation addresses recurrence patterns, treatment response, and options for further intervention. The evaluation process is conducted within the framework of the multidisciplinary tumor board, ensuring that neurosurgical, oncological, and radiotherapeutic perspectives are integrated before recommendations are communicated."
      patientPathway={[
        "Submit available medical reports, MRI/CT imaging, and pathology documentation through the secure online portal",
        "A clinical coordinator in Berlin reviews the submitted documentation and confirms receipt within 24–48 hours",
        "The case is presented to the relevant specialist or multidisciplinary team for preliminary assessment",
        "A structured evaluation report is prepared, outlining diagnostic completeness, treatment options, and recommended next steps",
        "Where appropriate, the case is directed to the relevant university hospital department for formal consultation",
        "Ongoing coordination supports the patient and referring physician throughout the treatment pathway"
      ]}
      relatedLinks={[
        { href: "/neurology-germany", label: "Neurology in Germany" },
        { href: "/brain-surgery-germany", label: "Brain Surgery in Germany" },
        { href: "/neurology-treatment-germany", label: "Neurology Treatment" },
        { href: "/advanced-diagnostics-germany", label: "Advanced Diagnostics" },
        { href: "/second-opinion-germany", label: "Second Medical Opinion" },
        { href: "/university-hospital-treatment-germany", label: "University Hospital Treatment" }
      ]}
      structuredData={JSON.stringify({
        "@context": "https://schema.org",
        "@type": "MedicalWebPage",
        "name": "Brain Tumor Treatment in Germany",
        "description": "Structured access to neurosurgical and neuro-oncological expertise at German university hospitals for brain tumor diagnosis and treatment.",
        "url": "https://www.medicalcaregermany.com/brain-tumor-treatment-germany",
        "about": { "@type": "MedicalCondition", "name": "Brain Tumor" },
        "publisher": { "@type": "Organization", "name": "Medical Care Germany", "url": "https://www.medicalcaregermany.com" }
      })}
      arabicSummary="أورام المخ هي نمو غير طبيعي للخلايا داخل الجمجمة، وقد تكون ابتدائية نشأت في أنسجة المخ، أو ثانوية انتقلت من عضو آخر في الجسم. تتفاوت الأعراض بحسب موقع الورم وقد تشمل الصداع المستمر، أو ضعف في الحركة، أو تغيرات في الكلام والذاكرة. في ألمانيا، تُعالج هذه الحالات ضمن فرق طبية متخصصة تضم جراحي الأعصاب وأطباء الأورام وأخصائيي الأشعة، مما يتيح وضع خطة علاجية دقيقة تناسب كل حالة على حدة. يمكن إرسال التقارير الطبية للتقييم الأولي قبل اتخاذ أي قرار علاجي."
    />
  );
}
